Skip to main content

ADVERTISEMENT

Joshua Loh, MD

Original Contribution
05/21/2014
A comparison of the long-term safety and clinical effectiveness of the Xience V everolimus-eluting stent to both the Taxus paclitaxel-eluting stent and the Cypher sirolimus-eluting stent in an unselected patient population.
A comparison of the long-term safety and clinical effectiveness of the Xience V everolimus-eluting stent to both the Taxus paclitaxel-eluting stent and the Cypher sirolimus-eluting stent in an unselected patient population.
A comparison of the long-term...
05/21/2014
Journal of Invasive Cardiology
04/15/2018
An evaluation of the 1-year clinical outcomes of patients treated with 2.0 mm drug-coated balloon vs 2.0 mm drug-eluting stent implantation in small-caliber vessel de novo coronary artery disease.
An evaluation of the 1-year clinical outcomes of patients treated with 2.0 mm drug-coated balloon vs 2.0 mm drug-eluting stent implantation in small-caliber vessel de novo coronary artery disease.
An evaluation of the 1-year...
04/15/2018
Journal of Invasive Cardiology
Original Contribution
05/29/2015
This study aimed to evaluate the safety and efficacy of everolimus-eluting stent (EES) use compared with first-generation drug-eluting stent (DES) use in diabetic patients undergoing multivessel percutaneous coronary intervention. In diabetic...
This study aimed to evaluate the safety and efficacy of everolimus-eluting stent (EES) use compared with first-generation drug-eluting stent (DES) use in diabetic patients undergoing multivessel percutaneous coronary intervention. In diabetic...
This study aimed to evaluate the...
05/29/2015
Journal of Invasive Cardiology